TipRanks
Go Ultimate55% OFF

ArriVent BioPharma, Inc. (AVBP) Cash flow

ArriVent BioPharma, Inc. Cash Flow

AVBP's free cash flow for Q2 2026 was $-39.58M. For the 2026 fiscal year, AVBP's free cash flow was increased by $0.00 and operating cash flow was $-39.58M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -160.59M$ -70.21M$ -55.84M$ -43.63M$ -12.59M
$ -71.23M$ -192.47M$ 0.00$ 0.00$ -40.00M
$ 203.06M$ 186.58M$ 42.86M$ 169.72M$ 89.87M
$ 45.54M$ 74.29M$ 150.39M$ 163.37M$ 37.28M
$ -160.59M$ -70.21M$ -55.84M$ -43.63M$ -12.59M

Currency in USD

ArriVent BioPharma, Inc. Cash Flow

-300M-200M-100M0100M200M300M20212022202320242025OperatingInvestingFinancing